The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBakkavor Regulatory News (BAKK)

Share Price Information for Bakkavor (BAKK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 115.00
Bid: 115.00
Ask: 117.00
Change: -2.50 (-2.13%)
Spread: 2.00 (1.739%)
Open: 120.50
High: 120.50
Low: 115.00
Prev. Close: 117.50
BAKK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Major Shareholder Change and Directorate Change

15 Jan 2024 07:17

RNS Number : 6063Z
Bakkavor Group PLC
15 January 2024
 

 15 January 2024

 

Bakkavor Group plc (the 'Company' or 'Bakkavor')

 

Major Shareholder Change and Directorate Change

 

 

On 12 January 2024, the Company was informed that BP-PE5 L.L.C. (an affiliate of the Baupost Group, "Baupost") had sold its entire shareholding of 116,468,928 ordinary shares (the "Shares"), representing 20.1% of the share capital in the Company to LongRange Capital Fund I, L.P. and its affiliates ("LongRange", and with respect to the share sale, the "Transaction").

 

Founded in 2019, LongRange was formed to take a longer-term perspective to investing and building middle market businesses through a company-focussed and customer-first philosophy. LongRange has over $1.7 billion in assets under management and employs a highly flexible and collaborative approach to partnering with management and other stakeholders.

Effective upon completion of the Transaction (expected to be on or around 16 January 2024), the Company's relationship agreement with Baupost dated 10 November 2017 will terminate and Patrick Cook, Baupost's nominated representative to the Company's Board, will step down.

The Company has today entered into a relationship agreement with LongRange ("the Relationship Agreement") which will come into effect automatically upon completion of the Transaction (expected to be on or around 16 January 2024). The Relationship Agreement will regulate the ongoing relationship between the Company and LongRange. The key terms of the Relationship Agreement will be made available on the Company's investor relation website at www.bakkavor.com/en/investors/shareholder-information.  

Pursuant to the Relationship Agreement, the Company also announces that Robert (Bob) Berlin will be appointed as a non-independent non-executive Director of the Company's Board, as LongRange's representative, and such appointment will also become effective upon completion of the Transaction.

Bob previously served as a non-executive Director of the Company, from January 2016 until July 2018.

Bob is a senior investment professional with investing and strategic operating experience across the consumer goods, food, manufacturing, technology and services sectors. He has helped management teams drive value creation through investments in innovation, accretive capital investments, new commercial relationships, data and analytics, organisational change and operational optimisation.

Simon Burke, Chairman, said:  "Baupost has been a supportive shareholder in Bakkavor over many years and we wish them well. Patrick Cook was a very positive addition to our Board, giving us insight, good challenge and constructive debate. I would like to thank him for this on behalf of us all and wish him every success in the future".

"In the meantime, I am delighted to welcome back Bob Berlin. He knows us and our markets very well, and I look forward to the Board having the benefit of his knowledge and energy once again."

 

Mike Edwards, CEO, said "I would like to extend a warm welcome to Bob Berlin, who rejoins our Board representing LongRange. He has a deep understanding of our business as well as our markets and his experience will be invaluable as we continue to build positive momentum and deliver our strategic ambition."

 

There are no further details to be disclosed pursuant to Listing Rule 9.6.13 in connection with Bob Berlin's appointment.

 

The Company will be issuing its scheduled FY23 Trading Update on Thursday,18th of January 2024.

 

In accordance with section 430(2B) of the Companies Act 2006, no remuneration payment or payment for loss of office will be made to Patrick Cook in connection with the termination of his appointment.

 

 

ENQUIRIES

Institutional investors and analysts:

Ben Waldron, Chief Financial Officer

+44 (0) 20 7908 6114

Annabel Tagoe-Bannerman, Group General Counsel & Company Secretary

+44 (0) 20 7908 6130

 

Financial media: bakkavor@mhpgroup.com +44 (0) 3128 8100 / + 44 7884 494112

Katie Hunt, MHP

Rachel Farrington, MHP

Oliver Hughes, MHP

 

About Bakkavor

We are the leading provider of fresh prepared food ("FPF") in the UK, and our presence in the US and China positions the Group well in these, high-growth markets. We leverage our consumer insight and scale to provide innovative food that offers quality, choice, convenience, and freshness. Over 18,500 colleagues operate from 44 sites across our three markets supplying a portfolio of over 2,900 products across meals, pizza & bread, salads and desserts to leading grocery retailers in the UK and US, and international food brands in China.

LEI number: 213800COL7AD54YU9949

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAVLLFFZFLFBBF
Date   Source Headline
12th Apr 20247:00 amRNSDirector/PDMR Shareholding
12th Apr 20247:00 amRNSDirector/PDMR Shareholding
2nd Apr 20241:15 pmRNSDirector Declaration
26th Mar 20241:00 pmRNSDirector/PDMR Shareholding
15th Mar 20247:00 amRNSAnnual Report and Accounts 2023 and Notice of AGM
5th Mar 20244:56 pmRNSFinal Dividend for Full Year 2023
5th Mar 20247:00 amRNSFull Year Results 2023
18th Jan 20247:00 amRNSFull Year 2023 Trading Update
15th Jan 20247:17 amRNSMajor Shareholder Change and Directorate Change
15th Jan 20247:00 amRNSHolding(s) in Company
15th Jan 20247:00 amRNSHolding(s) in Company
11th Jan 20243:48 pmRNSHolding(s) in Company
9th Oct 20233:37 pmRNSDirector/PDMR Shareholding
21st Sep 202312:07 pmRNSHolding(s) in Company
6th Sep 20237:00 amRNSHalf-year Report
20th Jul 202310:07 amRNSDirector Declaration
31st May 20233:11 pmRNSResult of AGM
31st May 20237:00 amRNSQ1 2023 Trading Update
23rd May 20237:00 amRNSDirector/PDMR Shareholding
10th May 20235:16 pmRNSDirector/PDMR Shareholding
13th Apr 20239:54 amRNSDirector/PDMR Shareholding
3rd Apr 20234:05 pmRNSDirector/PDMR Shareholding
29th Mar 202311:57 amRNSHolding(s) in Company
17th Mar 20237:00 amRNSAnnual Report and Accounts 2022 and Notice of AGM
8th Mar 20237:00 amRNSFull Year Results 2022
22nd Feb 20234:35 pmRNSPrice Monitoring Extension
19th Jan 20237:00 amRNSFull year 2022 trading update
18th Jan 20236:00 pmRNSRPS Group
16th Dec 20224:40 pmRNSSecond Price Monitoring Extn
16th Dec 20224:35 pmRNSPrice Monitoring Extension
23rd Nov 20227:00 amRNSQ3 2022 trading update
18th Nov 20227:00 amRNSBoard Committee Membership Changes
13th Oct 20224:05 pmRNSDirector/PDMR Shareholding
10th Oct 20224:35 pmRNSPrice Monitoring Extension
29th Sep 20227:00 amRNSDirectorate Change
21st Sep 20224:41 pmRNSSecond Price Monitoring Extn
21st Sep 20224:35 pmRNSPrice Monitoring Extension
12th Sep 20224:36 pmRNSPrice Monitoring Extension
7th Sep 20227:00 amRNSHalf-year Report
22nd Aug 20224:41 pmRNSSecond Price Monitoring Extn
22nd Aug 20224:35 pmRNSPrice Monitoring Extension
9th Aug 20224:36 pmRNSPrice Monitoring Extension
11th Jul 20224:36 pmRNSPrice Monitoring Extension
22nd Jun 20224:36 pmRNSPrice Monitoring Extension
7th Jun 20227:30 amRNSDirector Declaration
30th May 20224:36 pmRNSPrice Monitoring Extension
27th May 20222:03 pmRNSDirector/PDMR Shareholding
25th May 20223:09 pmRNSResult of AGM
25th May 20221:38 pmRNSDirector/PDMR Shareholding
25th May 20227:00 amRNSQ1 2022 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.